Explanation of how the number of participants for analysis was determined.
Includes whether analysis was per protocol, intention to treat, or another method.
Also provides relevant details such as imputation technique, as appropriate.

No text entered.

Reporting Groups

Description

Switch Group

Participants will switch to aripiprazole.

Stay Group

Participants will continue treatment with olanzapine, quetiapine, or risperidone.